Initiation of sodium polystyrene sulphonate and the risk of gastrointestinal adverse events in advanced chronic kidney disease: a nationwide study

BACKGROUND: Despite long-standing clinical use of sodium polystyrene sulphonate (SPS) for hyperkalaemia management in chronic kidney disease (CKD), its safety profile remains poorly investigated. METHODS: We undertook an observational analysis of nephrology-referred adults with incident CKD Stage 4+...

Descripción completa

Detalles Bibliográficos
Autores principales: Laureati, Paola, Xu, Yang, Trevisan, Marco, Schalin, Lovisa, Mariani, Illaria, Bellocco, Rino, Sood, Manish M, Barany, Peter, Sjölander, Arvid, Evans, Marie, Carrero, Juan J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473802/
https://www.ncbi.nlm.nih.gov/pubmed/31377791
http://dx.doi.org/10.1093/ndt/gfz150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473802/
https://www.ncbi.nlm.nih.gov/pubmed/31377791
http://dx.doi.org/10.1093/ndt/gfz150

Ejemplares similares